Psilocybin Mushrooms in Wisconsin: Therapy Uses, Legality & Access

Psilocybin Mushrooms in Wisconsin: An In-Depth Look

Psilocybin mushrooms, often referred to as "magic mushrooms", contain the psychedelic compound psilocybin. While illegal in most of the United States, efforts to decriminalize or legalize magic mushrooms specifically for mental health treatment are gaining momentum.

The History of Magic Mushrooms

Psilocybin mushrooms have been used by ancient indigenous cultures for millennia during spiritual ceremonies and rituals. First clinically studied in the 1950s, research into the therapeutic potential of psilocybin was sadly halted for decades before undergoing a revival over the past 10-15 years.

Psilocybin Mushroom Species in Wisconsin

Wisconsin is home to over 10 psilocybin-containing mushroom species, most commonly:

• Psilocybe caerulipes (bluing foot mushrooms)
• Psilocybe ovoideocystidiata (egg-shaped psilocybe)
• Galerina marginata (deadly galerina - toxic, not psychoactive)
• Gymnopilus aeruginosa (big laughing gym)

These mushrooms thrive during warmer months in moist, humid environments enriched with decaying organic matter like woodchips, mulch, manure, and dead leaves.

The Science Behind Psilocybin

How Psilocybin Works in the Brain

As a serotonergic psychedelic compound, psilocybin acts as an agonist (activator) of specific serotonin receptors in the brain, primarily 5-HT2A receptors. This stimulate increased communication between neurons and heightened activity in regions involving mood, sensory perception, self-awareness, and introspection.

Short and Long-Term Effects on the Brain

In the short term, psilocybin alters consciousness, emotion, cognition, vision, hearing, and one's sense of time and identity. Effects typically last for 4-6 hours. Psilocybin may also change brain structure and function over the long term by forming new connections and patterns of activity among neurons.

The Clinical Applications of Psilocybin

Treating Depression

A number of studies show rapid, sustained, and significant improvement in depressive symptoms after just 1-3 guided psilocybin therapy sessions combined with psychotherapy. MRI scans confirm increased neural connections and activity patterns associated with mood regulation being formed.

Reducing Anxiety

Research indicates that psilocybin-assisted therapy blunts activity in brain circuitry linked to obsessive, fearful thinking while enhancing optimism, self-compassion, and equanimity. It allows people to address anxiety triggers from a new perspective.

Managing PTSD Symptoms

By temporarily altering the brain's entrenched pathways, psilocybin provides trauma survivors a window to process painful memories more objectively with trained therapists. Brain scans show weaker connections to regions responsible for distress.

Supporting Substance Addiction Recovery

Several key studies reveal that psilocybin therapy paired with talk therapy empowers people overcoming addiction (especially smoking) via mystical-type experiences that shift worldviews and identity not centered on drug use.

Improving End-of-Life Distress

Research shows psilocybin can significantly decrease end-of-life anxiety, depression, hopelessness, and existential distress in terminally ill patients by reframing their attitudes about death and dying.

What to Expect During Psilocybin-Assisted Therapy

Screening and Preparation

Clients undergo medical screening to verify safety along with preparatory counseling sessions to establish trust with therapists and set intentions. They may be asked to taper off any psychiatric medications before proceeding.

Dosing Sessions

In a comfortable, aesthetic environment with a male and female therapist present, participants take measured oral doses of psilocybin. Therapists provide empathetic guidance and support as needed while peaceful music plays.

Integration

Multiple psychotherapy sessions help integrate breakthrough insights, perspectives, emotions, and visions from the psilocybin experience into everyday life in a sustainable way.

The Risks and Legality of Psilocybin Use

While generally safe under medical supervision, potential risks of psilocybin for some include:

• Short-term anxiety or paranoia
• Elevated blood pressure and heart rate
• Exacerbation of serious mental illness like schizophrenia
• Impaired cognition or coordination persisting after acute effects wear off

In most places, psilocybin mushrooms remain illegal outside authorized clinical trials. Some US cities have decriminalized natural psychedelics, while Oregon legalized regulated supervised psilocybin services in late 2020. As stigma fades and research expands, more jurisdictions hope to follow Oregons lead in providing access to psilocybin therapy.

Seeking Psilocybin Therapy in Wisconsin

At this time, psilocybin is still classified as a Schedule I illegal drug without approved medical uses in Wisconsin. While efforts to pass decriminalization bills have occurred, none have yet succeeded.

The Usona Institute hopes to launch psilocybin therapy clinical trials in Wisconsin pending FDA approval. Interested individuals may visit their website to learn about enrolling as a participant if trials open near the Madison area.

Until policy changes unfold, possessing or using psilocybin mushrooms remains prohibited in Wisconsin even for those with treatment-resistant mental health conditions that psilocybin could greatly help.

What the Future May Hold

As leading medical organizations and renowned researchers call for expanded psilocybin research and access, it seems likely that psilocybin therapy will slowly gain greater acceptance and become lawfully available to patients in need.

Key factors enabling this include the profound, rapid effects psilocybin therapy demonstrates for anxiety, depression, addiction, PTSD and end-of-life psychospiritual distress. Stay tuned for potential developments in Wisconsin and beyond.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.